Short answer · Medically reviewed summary · Last updated: 2026-04-07
Duchenne muscular dystrophy (DMD) is most commonly referred to by its full name or the abbreviation DMD, though it was historically known as pseudohypertrophic muscular dystrophy. While medical terminology has evolved to be more precise, you may encounter various terms in older medical records or international literature that all describe this specific X-linked progressive muscle disorder. What are the common synonyms and abbreviations for Duchenne muscular dystrophy? In contemporary clinical practice, Duchenne muscular dystrophy is the standard nomenclature used by physicians and researchers worldwide.
Duchenne muscular dystrophy synonyms
Other names for Duchenne muscular dystrophy: synonyms, acronyms and related terms used by doctors and patients.
Duchenne muscular dystrophy (DMD) is most commonly referred to by its full name or the abbreviation DMD, though it was historically known as pseudohypertrophic muscular dystrophy. While medical terminology has evolved to be more precise, you may encounter various terms in older medical records or international literature that all describe this specific X-linked progressive muscle disorder.
What are the common synonyms and abbreviations for Duchenne muscular dystrophy?
In contemporary clinical practice, Duchenne muscular dystrophy is the standard nomenclature used by physicians and researchers worldwide. The most frequent abbreviation is simply DMD. Because Duchenne muscular dystrophy is a genetic condition characterized by the absence of the protein dystrophin, it is sometimes classified under the broader clinical umbrella of dystrophinopathies. Understanding these terms is essential when reviewing medical records or searching for updated clinical trials, as some databases may use variations of these names to categorize patient data.
What historical names were used for Duchenne muscular dystrophy?
Historically, the condition was frequently described by the physical appearance of the affected muscles. Before the genetic basis of Duchenne muscular dystrophy was fully understood, it was commonly called "pseudohypertrophic muscular dystrophy" because the calf muscles often appeared enlarged due to the replacement of muscle tissue with fat and connective tissue. You may see this term in medical literature published prior to the 1980s. Another, less common historical term is "Duchenne-type muscular dystrophy," named after the French neurologist Guillaume Benjamin Amand Duchenne, who provided the first detailed clinical description of the disease in the 1860s.
How is Duchenne muscular dystrophy classified in medical databases?
Standardized medical classification systems provide consistency across global healthcare systems. Using these official identifiers can help you find accurate information on platforms like DiseaseMaps.org or when speaking with specialists. Key identifiers for Duchenne muscular dystrophy include:
- OMIM (Online Mendelian Inheritance in Man): #310200
- Orphanet: ORPHA98896
- ICD-10-CM: G71.01 (Duchenne or Becker muscular dystrophy)
- ICD-11: 8D80.00 (Duchenne muscular dystrophy)
Why are there multiple names for this condition?
The variety of names for Duchenne muscular dystrophy stems from the evolution of medical knowledge. Early naming conventions were based on observable clinical symptoms (like pseudohypertrophy), whereas modern naming conventions are based on the underlying genetic mutation and protein deficiency. As diagnostic technology improved, medical bodies moved toward using the eponym "Duchenne" to honor the physician who first identified the clinical pattern, combined with the specific pathological description of the muscle degeneration. Today, Duchenne muscular dystrophy is the preferred term, as it is globally recognized and allows for clear communication between families, clinicians, and researchers.
Next steps
- Consult with a neuromuscular specialist or pediatric neurologist to confirm the specific genetic diagnosis in your medical records.
- Join the 38 members of the DiseaseMaps community who are navigating life with Duchenne muscular dystrophy to share experiences and local resources.
- Use the official OMIM or Orphanet codes provided above when searching for clinical trials or specialized care centers.
- Connect with patient advocacy organizations, such as Parent Project Muscular Dystrophy (PPMD), for the most recent updates on therapeutic developments.
Medical disclaimer: This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.
